Literature DB >> 12581498

Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.

Tânia Silvia Fröde1, Patrícia Tenconi, Marilei Reynaud Debiasi, Yara Santos Medeiros.   

Abstract

BACKGROUND AND AIMS: Although the participation of cytokines in the pathogenesis of rheumatoid arthritis (RA) seems to be unequivocal, their relationship with current serum markers of this disease is not clear. The present study analyses whether there is any correlation between the levels of tumour necrosis factor-alpha (TNF-alpha), interleukin-2 soluble receptor (sIL-2R) and the concentrations of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and beta(2)-microglobulin in a group of 21 patients with RA, all rheumatoid factor positive.
METHODS: The levels of TNF-alpha and sIL-2R were analysed in association with other parameters of inflammation (ESR, CRP and beta(2)-microglobulin).
RESULTS: In comparison with the control group, RA patients presented high median levels of both cytokines, TNF-alpha (6.4 pg/ml) and sIL-2R (56 pmol/L), as well as of ESR (34 mm/h), CRP (0.9 mg/dl) and beta(2)-microglobulin (1.6 mg/dl) (p < 0.01). However, only ESR levels in the RA group significantly differ from the control group (p < 0.01). No correlation was found between the inflammatory parameters.
CONCLUSIONS: These results suggested that TNF-alpha and slL-2R levels are up-regulated in RA patients but did not significantly differ from the control group. Due to the chronic course of this disease, other inflammatory markers must be identified in order to provide early therapeutic strategies to these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12581498      PMCID: PMC1781685          DOI: 10.1080/0962935021000051539

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  16 in total

1.  Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.

Authors:  R H Straub; M Zeuner; E Antoniou; J Schölmerich; B Lang
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

Review 2.  Cytokines in rheumatoid arthritis: trials and tribulations.

Authors:  N L Carteron
Journal:  Mol Med Today       Date:  2000-08

Review 3.  Cytokines in rheumatoid arthritis.

Authors:  A E Koch; S L Kunkel; R M Strieter
Journal:  J Investig Med       Date:  1995-02       Impact factor: 2.895

4.  Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.

Authors:  A Spadaro; E Taccari; V Riccieri; F Sensi; A Sili Scavalli; A Zoppini
Journal:  Rev Rhum Engl Ed       Date:  1997-02

Review 5.  Laboratory markers of disease activity.

Authors:  C Richardson; P Emery
Journal:  J Rheumatol Suppl       Date:  1996-03

6.  Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

Authors:  D M Butler; R N Maini; M Feldmann; F M Brennan
Journal:  Eur Cytokine Netw       Date:  1995 Jul-Dec       Impact factor: 2.737

Review 7.  Connective tissue markers of rheumatoid arthritis.

Authors:  H J Møller
Journal:  Scand J Clin Lab Invest       Date:  1998-07       Impact factor: 1.713

8.  Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.

Authors:  Y Suenaga; M Yasuda; M Yamamoto; S Nonaka; T Wada; S Shiokawa; M Nobunaga
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 9.  Rheumatoid arthritis: a medical emergency?

Authors:  T Pincus
Journal:  Scand J Rheumatol Suppl       Date:  1994

Review 10.  The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995.

Authors:  R N Maini
Journal:  J R Coll Physicians Lond       Date:  1996 Jul-Aug
View more
  5 in total

1.  Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines: Lactobacillus casei: COX-2 inhibitor.

Authors:  Sarika Amdekar; Vinod Singh; Rambir Singh; Poonam Sharma; Poonam Keshav; Avnish Kumar
Journal:  J Clin Immunol       Date:  2010-09-14       Impact factor: 8.317

2.  Lactobacillus acidophilus Protected Organs in Experimental Arthritis by Regulating the Pro-inflammatory Cytokines.

Authors:  Sarika Amdekar; Vinod Singh; Avnish Kumar; Poonam Sharma; Rambir Singh
Journal:  Indian J Clin Biochem       Date:  2013-11-27

3.  Detection of salivary interleukin-2 in recurrent aphthous stomatitis.

Authors:  R Kalpana; M Thubashini; B Sivapatha Sundharam
Journal:  J Oral Maxillofac Pathol       Date:  2014 Sep-Dec

4.  Enhanced reactivity to pain in patients with rheumatoid arthritis.

Authors:  Robert R Edwards; Ajay D Wasan; Clifton O Bingham; Joan Bathon; Jennifer A Haythornthwaite; Michael T Smith; Gayle G Page
Journal:  Arthritis Res Ther       Date:  2009-05-04       Impact factor: 5.156

Review 5.  On the role of sIL-2R measurements in rheumatoid arthritis and cancers.

Authors:  Anna Maria Witkowska
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.